Latest stories on AMRN
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - qz.com
Quartz56 · neutralgeneral
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
Business Insider63 · neutralproduct/pr
Amarin analysis links Vascepa adherence to greater, longer-lasting heart benefits
Seeking Alpha67 · bullishproduct/pr
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
Business Insider55 · neutralproduct/pr
Amarin reinstated with an Underweight at JPMorgan
The Fly34 · bearishanalyst
Amarin (AMRN) Q2 2026 Earnings Call Transcript
The Motley Fool59 · neutralearnings
Amarin expects positive full-year 2026 cash flow as VASCEPA market share reaches 48% and Europe demand rises 69%
Seeking Alpha67 · bullishproduct/pr
Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
AMARIN CORP PLC\UK (AMRN) files 8-K
SEC 8-K50 · neutralgeneral
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
InvestorsHub63 · neutralearnings
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
Yahoo Top63 · neutralearnings
Amarin Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings
Amarin misses Q2 topline estimates
Seeking Alpha34 · bearishearnings
Amarin: The Market Is Pricing A 55% Chance Of A Sale That Isn't Coming
Seeking Alpha32 · bearishanalyst
Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Seeking Alpha28 · bearishgeneral